348 related articles for article (PubMed ID: 4042422)
1. Surface markers and cytotoxic activity of blood natural killer cells studied at the single cell level in Hodgkin's disease.
Jezewska E; Björkholm M; Giscombe R; Holm G; Tullgren O
Clin Exp Immunol; 1985 Jul; 61(1):96-102. PubMed ID: 4042422
[TBL] [Abstract][Full Text] [Related]
2. Normal natural killer cell activity in Hodgkin's disease patients in remission.
Douer D; Shaked N; Ramot B
Clin Exp Immunol; 1987 Sep; 69(3):660-7. PubMed ID: 3665188
[TBL] [Abstract][Full Text] [Related]
3. Frequent T4-positive cells with cytolytic activity in spleens of patients with Hodgkin's disease (a clonal analysis).
Maggi E; Parronchi P; Del Prete G; Ricci M; Bosi A; Moretta L; Romagnani S
J Immunol; 1986 Feb; 136(4):1516-20. PubMed ID: 3080527
[TBL] [Abstract][Full Text] [Related]
4. [The effect of sera of breast cancer patients on NK cell activity].
Konjević G; Spuzić I
Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
[TBL] [Abstract][Full Text] [Related]
5. Natural killer activity in spleens and lymph nodes from patients with Hodgkin's disease.
Ruco LP; Procopio A; Uccini S; Marcorelli E; Baroni CD
Cancer Res; 1982 May; 42(5):2063-8. PubMed ID: 6175405
[TBL] [Abstract][Full Text] [Related]
6. Defective NK cell activity following thermal injury.
Klimpel GR; Herndon DN; Fons M; Albrecht T; Asuncion MT; Chin R; Stein MD
Clin Exp Immunol; 1986 Nov; 66(2):384-92. PubMed ID: 3493101
[TBL] [Abstract][Full Text] [Related]
7. Functional characterization of LFA-1 antigens in the interaction of human NK clones and target cells.
Schmidt RE; Bartley G; Levine H; Schlossman SF; Ritz J
J Immunol; 1985 Aug; 135(2):1020-5. PubMed ID: 3924996
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.
Katz JD; Mitsuyasu R; Gottlieb MS; Lebow LT; Bonavida B
J Immunol; 1987 Jul; 139(1):55-60. PubMed ID: 3584988
[TBL] [Abstract][Full Text] [Related]
9. Natural killer (NK) activity in patients with Hodgkin's disease before, during and after multiple-agent therapy.
Frydecka I; Kotlarek-Haus S; Kuliszkiewicz-Janus M; Kuliczkowski K
Arch Immunol Ther Exp (Warsz); 1990; 38(5-6):407-14. PubMed ID: 2130805
[TBL] [Abstract][Full Text] [Related]
10. Increased number of functionally defective large granular lymphocytes in lymphoma patients.
Muhonen T; Teerenhovi L; Saksela E
Nat Immun Cell Growth Regul; 1987; 6(2):57-64. PubMed ID: 3600676
[TBL] [Abstract][Full Text] [Related]
11. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
[TBL] [Abstract][Full Text] [Related]
12. Interferon enhanced natural killer function in Hodgkin's disease.
Levy S; Reins F; Aleksijevic A; Giron C; Oberling F; Mayer S; Lang JM
Nouv Rev Fr Hematol (1978); 1986; 28(5):323-5. PubMed ID: 3808943
[TBL] [Abstract][Full Text] [Related]
13. A comparison of membrane markers on rat cytotoxic cells.
Cantrell DA; Robins RA; Baldwin RW
Immunology; 1983 May; 49(1):139-46. PubMed ID: 6220963
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
Bonavida B; Lebow LT; Bradley TP
J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
[TBL] [Abstract][Full Text] [Related]
15. Characterization of HNK-1+ (Leu-7) human lymphocytes. I. Two distinct phenotypes of human NK cells with different cytotoxic capability.
Abo T; Cooper MD; Balch CM
J Immunol; 1982 Oct; 129(4):1752-7. PubMed ID: 6980948
[TBL] [Abstract][Full Text] [Related]
16. [Effect of interferon-alpha (MOR-22) on human NK cell activity].
Yanagihara Y; Tochizawa S; Ishii K; Hirai Y
Gan To Kagaku Ryoho; 1986 Feb; 13(2):342-8. PubMed ID: 3947110
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic and functional characterization of the circulating NK compartment in hairy cell leukaemia.
Foa R; Lauria F; Lusso P; Raspadori D; Fierro MT; Tazzari PL; Caudana L; Matera L
Clin Exp Immunol; 1986 May; 64(2):392-8. PubMed ID: 3742880
[TBL] [Abstract][Full Text] [Related]
18. Surface antigens and cytotoxic natural killer cell (NK) activity of blood lymphocytes in heavy cigarette smokers.
Jezewska E; Dworacki G; Skrzypczak A; Zeromski J
Arch Geschwulstforsch; 1990; 60(3):187-92. PubMed ID: 2369281
[TBL] [Abstract][Full Text] [Related]
19. Mode of in vitro augmentation of natural killer cell activity by recombinant human interleukin 2: a comparative study of Leu-11+ and Leu-11- cell populations in cord blood and adult peripheral blood.
Seki H; Ueno Y; Taga K; Matsuda A; Miyawaki T; Taniguchi N
J Immunol; 1985 Oct; 135(4):2351-6. PubMed ID: 3928745
[TBL] [Abstract][Full Text] [Related]
20. Defective natural cytotoxicity in patients with cancer: normal number of effector cells but decreased recycling capacity in patients with advanced disease.
Steinhauer EH; Doyle AT; Reed J; Kadish AS
J Immunol; 1982 Nov; 129(5):2255-9. PubMed ID: 7119445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
